Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,628 | 28,527 | 25,617 | 42,168 | 54,381 |
| Receivables | 149,142 | 146,736 | 137,231 | 138,882 | 128,680 |
| Inventories | 31,648 | 31,613 | 29,363 | 30,273 | 31,948 |
| TOTAL | $277,999 | $244,683 | $220,699 | $245,591 | $247,658 |
| Non-Current Assets | |||||
| PPE Net | 95,256 | 92,850 | 93,038 | 88,863 | 86,803 |
| Intangibles | 145,691 | 145,784 | 145,840 | 143,636 | 139,188 |
| Other Non-Current Assets | 35,480 | 39,591 | 45,213 | 56,256 | 52,310 |
| TOTAL | $276,427 | $278,225 | $284,091 | $288,755 | $278,301 |
| Total Assets | $554,426 | $522,908 | $504,790 | $534,346 | $525,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 300,767 | 1,906 | 3,027 | 5 | 680 |
| Accounts payable and accrued liabilities | 38,683 | 35,690 | 39,861 | 45,598 | 48,249 |
| Accrued Expenses | 25,590 | 27,156 | 25,689 | 27,448 | 24,593 |
| TOTAL | $390,294 | $93,477 | $98,040 | $114,957 | $99,302 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 300,000 | 300,000 | 300,001 | 300,002 |
| Deferred Revenues | 8,890 | 9,537 | 9,130 | 6,569 | 7,584 |
| Other Non-Current Liabilities | 54,773 | 54,747 | 44,607 | 50,928 | 49,747 |
| TOTAL | $54,850 | $354,850 | $344,607 | $350,929 | $349,749 |
| Total Liabilities | $445,144 | $448,327 | $442,647 | $465,886 | $449,051 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,008 | 45,975 | 45,924 | 46,694 | 47,124 |
| Common Shares | 1,449 | 1,310 | 1,300 | 1,360 | 1,356 |
| Retained earnings | 376,833 | 91,829 | 62,496 | 116,848 | 85,334 |
| Other shareholders' equity | 575 | 552 | 347 | -2,072 | -1,816 |
| TOTAL | $109,282 | $74,581 | $62,143 | $68,460 | $76,908 |
| Total Liabilities And Equity | $554,426 | $522,908 | $504,790 | $534,346 | $525,959 |